NCT00129727View on ClinicalTrials.gov

Carboplatin Taxol Avastin in Ovarian Cancer (OVCA)

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Ovarian Cancer
Interventions
DRUG

Paclitaxel

Given intravenously

DRUG

Carboplatin

Given intravenously

DRUG

Bevacizumab

Given intravenously

All Listed Sponsors
collaborator

Women and Infants Hospital of Rhode Island

OTHER

lead

Massachusetts General Hospital

OTHER

NCT00129727 - Carboplatin Taxol Avastin in Ovarian Cancer (OVCA) | Biotech Hunter | Biotech Hunter